16-46584088-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_024745.5(SHCBP1):c.1466G>A(p.Gly489Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000279 in 1,436,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024745.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHCBP1 | NM_024745.5 | c.1466G>A | p.Gly489Asp | missense_variant, splice_region_variant | 11/13 | ENST00000303383.8 | NP_079021.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHCBP1 | ENST00000303383.8 | c.1466G>A | p.Gly489Asp | missense_variant, splice_region_variant | 11/13 | 1 | NM_024745.5 | ENSP00000306473.3 | ||
SHCBP1 | ENST00000567698.1 | n.166G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000931 AC: 2AN: 214722Hom.: 0 AF XY: 0.0000174 AC XY: 2AN XY: 114662
GnomAD4 exome AF: 0.00000279 AC: 4AN: 1436156Hom.: 0 Cov.: 29 AF XY: 0.00000421 AC XY: 3AN XY: 711848
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.1466G>A (p.G489D) alteration is located in exon 11 (coding exon 11) of the SHCBP1 gene. This alteration results from a G to A substitution at nucleotide position 1466, causing the glycine (G) at amino acid position 489 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at